Acasti Pharma Inc. (ACST)
NASDAQ: ACST · IEX Real-Time Price · USD
2.850
-0.040 (-1.38%)
At close: Jul 2, 2024, 3:54 PM
2.750
-0.100 (-3.51%)
After-hours: Jul 2, 2024, 5:48 PM EDT
Acasti Pharma Market Cap
Acasti Pharma has a market cap or net worth of $26.79 million as of July 2, 2024. Its market cap has increased by 10.70% in one year.
Market Cap
26.79M
Enterprise Value
9.96M
1-Year Change
10.70%
Ranking
Category
Stock Price
$2.85
Market Cap Chart
Since February 14, 2012, Acasti Pharma's market cap has decreased from $3.44B to $26.79M, a decrease of -99.22%. That is a compound annual growth rate of -32.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 26.80M | -1.47% |
| Dec 29, 2023 | 27.20M | 21.43% |
| Dec 30, 2022 | 22.40M | -59.86% |
| Dec 31, 2021 | 55.80M | 77.14% |
| Dec 31, 2020 | 31.50M | -84.91% |
| Dec 31, 2019 | 208.70M | 584.26% |
| Dec 31, 2018 | 30.50M | 119.42% |
| Dec 29, 2017 | 13.90M | 3.73% |
| Dec 30, 2016 | 13.40M | -98.71% |
| Dec 31, 2014 | 1.04B | -60.00% |
| Dec 31, 2013 | 2.60B | -41.91% |
| Dec 31, 2012 | 4.48B | 30.50% |
| Feb 14, 2012 | 3.44B | - |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bolt Biotherapeutics | 28.60M |
| Streamline Health Solutions | 28.58M |
| ProMIS Neurosciences | 28.44M |
| Orgenesis | 28.33M |
| Rapid Micro Biosystems | 28.29M |
| NeuroBo Pharmaceuticals | 27.44M |
| RenovoRx | 27.07M |
| Movano | 27.02M |